Title of article
The role of low avidity T cells in the protection against type 1 diabetes: A modeling investigation
Author/Authors
Khadra، نويسنده , , Anmar and Santamaria، نويسنده , , Pere and Edelstein-Keshet، نويسنده , , Leah، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2009
Pages
16
From page
126
To page
141
Abstract
Cytotoxic T lymphocytes (CTLs) play a dominant role in the pathogenesis of autoimmune diabetes, commonly denoted Type 1 Diabetes (T1D). These CTLs (notably CD 8 + T cells) recognize and kill insulin-secreting pancreatic β cells, reducing their number by ∼ 90 % . The resulting reduction of insulin secretion causes the defective regulation of glucose metabolism, leading to the characteristic symptoms of diabetes. Recognition of β cells as targets by CTLs depends on the interactions between MHC-peptide complexes on the surface of β cells and receptors (TCRs) on T cells. Those CTLs with high affinity TCRs (also called high avidity T cells) cause most of the harm, while those with low affinity TCRs (also called low avidity T cells) play a more mysterious role. Recent experimental evidence suggests that low avidity T cells accumulate as memory T cells during the disease and may be protective in NOD mice (a strain prone to developing T1D), delaying disease progression. It has been hypothesized that such low avidity T cells afford disease protection either by crowding the islets of Langerhans, where β cells reside, or by killing antigen presenting cells (APCs).
s paper, we explore the hypothesized mechanisms for this protective effect in the context of a series of models for (1) the interactions of low and high avidity T cells, (2) the effect of APCs and (3) the feedback from β cell killing to autoantigen-induced T cell proliferation. We analyze properties of these models, noting consistency of predictions with observed behaviour. We then use the models to examine the influence of various treatment strategies on the progression of the disease. The model reveals that progressive accumulation of memory low avidity autoreactive T cells during disease progression makes treatments aimed at expanding these protective T cell types more effective close to, or at the onset of clinical disease. It also provides evidence for the hypothesis that low avidity T cells kill APCs (rather than the alternate hypothesis that they crowd the islets).
Keywords
Antigen-presenting cell (APC) , T cell avidity , MODELING , ? Cell , diabetes
Journal title
Journal of Theoretical Biology
Serial Year
2009
Journal title
Journal of Theoretical Biology
Record number
1539533
Link To Document